Abstract
Cycloleucine (CL), a non-metabolizable amino acid analogue, was found to reduce thymus and spleen weights in Semliki Forest virus (SFV) strain A7(74) infected and control mice. The maximum effects were seen when three daily doses of CL were given to mice 24 h after an SFV A7(74) infection. In these mice thymus atrophy led to abolition of thymus dependent immune responses and changes in the pathological features of the viral infection--the most striking feature being prevention of demyelination. In addition virus titres in the brains of CL treated infected mice were increased and prolonged. These results show that demyelination following an SFV A7(74) infection is not a result of direct virus action, but of a T-cell mediated mechanism.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aviado D. M., Reutter H. A., Jr Pathologic physiology and chemotherapy of Plasmodium berghei. IX. Gastric secretion and the influence of 1-aminocyclopentane carboxylic acid (WR 14, 997 or cycloleucine). Exp Parasitol. 1969 Dec;26(3):314–322. doi: 10.1016/0014-4894(69)90124-6. [DOI] [PubMed] [Google Scholar]
- Fazakerley J. K., Amor S., Webb H. E. Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS. Clin Exp Immunol. 1983 Apr;52(1):115–120. [PMC free article] [PubMed] [Google Scholar]
- Fazakerley J. K., Webb H. E. Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation. Br J Exp Pathol. 1987 Feb;68(1):101–113. [PMC free article] [PubMed] [Google Scholar]
- Frisch A. W. Inhibition of antibody synthesis by cycloleucine. Biochem Pharmacol. 1969 Jan;18(1):256–260. doi: 10.1016/0006-2952(69)90035-5. [DOI] [PubMed] [Google Scholar]
- Frisch A. W., Wilson B. J. Cell transfer studies in immunosuppressed mice: the role of the macrophage. Proc Soc Exp Biol Med. 1969 Oct;132(1):42–45. doi: 10.3181/00379727-132-34144. [DOI] [PubMed] [Google Scholar]
- Greco C. M., Powell H. C., Garrett R. S., Lampert P. W. Cycloleucine encephalopathy. Neuropathol Appl Neurobiol. 1980 Sep-Oct;6(5):349–360. doi: 10.1111/j.1365-2990.1980.tb00671.x. [DOI] [PubMed] [Google Scholar]
- Jagelman S., Suckling A. J., Webb H. E., Bowen F. T. The pathogenesis of avirulent Semliki Forest virus infections in athymic nude mice. J Gen Virol. 1978 Dec;41(3):599–607. doi: 10.1099/0022-1317-41-3-599. [DOI] [PubMed] [Google Scholar]
- Kelly W. R., Blakemore W. F., Jagelman S., Webb H. E. Demyelination induced in mice by avirulent Semliki Forest virus. II. An ultrastructural study of focal demyelination in the brain. Neuropathol Appl Neurobiol. 1982 Jan-Feb;8(1):43–53. doi: 10.1111/j.1365-2990.1982.tb00256.x. [DOI] [PubMed] [Google Scholar]
- Rosenthale M. E., Datko L. J., Kassarich J., Schneider F. Chemotherapy of experimental allergic encephalomyelitis (EAE). Arch Int Pharmacodyn Ther. 1969 Jun;179(2):251–275. [PubMed] [Google Scholar]
- STERLING W. R., HENDERSON J. F. Studies of the mechanism of action 1-aminocyclopentane-1-carboxylic acid. Biochem Pharmacol. 1963 Apr;12:303–316. doi: 10.1016/0006-2952(63)90055-8. [DOI] [PubMed] [Google Scholar]
- Savlov E. D., MacIntyre J. M., Knight E., Wolter J. Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):21–27. [PubMed] [Google Scholar]
- Suckling A. J., Jagelman S., Webb H. E. Brain lysosomal glycosidase activity in immunosuppressed mice infected with avirulent Semliki forest virus. Infect Immun. 1977 Feb;15(2):386–391. doi: 10.1128/iai.15.2.386-391.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]